@kainvests · Long IOVA · The Analysts

Call · @kainvests · #8 on the leaderboard

@kainvests

@kainvests · Mon, Aug 3

$IOVA 🗞️ It’s official: IOV-SAR-201 is with us! https://t.co/ZdPCwRllAc Sarcomas affect over 8,000 patients in the US and Europe, and there are no immunotherapy options. Second-line standards of care (SoC) typically yield an ORR of less than 5%, with mPFS of only approximately

46d agoview on X ↗

tweeted Mon, Aug 3 · counted from Tue, Aug 4 close

Read as

Long IOVA · High confidence

Confidence

High0.90

Counted from

Tue, Aug 4 · market close

Rank since this call

—

Sep 11

#38

Sep 13

Sep 14

Sep 15

—

Sep 16

Sep 17

Leaderboard position per scored day, never a price chart. Other calls were active in this window; no single call is credited.